Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.
about
Vaccination-induced noncytolytic effects in the acute phase of SHIV infectionHIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin familyNovel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophagesSerpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replicationProthymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction.Anti-HSV activity of serpin antithrombin III.In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.Control of HIV-1 infection by soluble factors of the immune response.Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progressionInitial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replicationSecretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usageEpigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replicationCD8(+) lymphocytes suppress human immunodeficiency virus 1 replication by secreting type I interferons.CD8+ T cell control of HIV--a known unknown.The CD8 antiviral factor (CAF) can suppress HIV-1 transcription from the long terminal repeat (LTR) promoter in the absence of elements upstream of the CATATAA box.Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor.Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-ceChanges in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression
P2860
Q27313589-758E1A01-8D1F-4D81-A114-7C58DA8284E4Q28214202-A530B1C3-39E2-43B2-9E33-C2E0659A8AEBQ30445480-F9FA66D6-4CE3-4D50-97B6-7628054FA469Q33886860-3DEBE205-300E-4D35-A2B8-FD557B592A90Q33933182-058EA418-4DBA-49A9-A56B-E2D5CE393B4EQ34152714-D88EF790-F312-46C4-AE65-BAE8CEAF034CQ34469655-6BBACDB5-D8F7-4CA4-BFDF-098D60582784Q35752416-1DBB691C-AFC8-4D65-8154-8A466BBBF49FQ35769177-2E4E408A-2B48-4FE9-AD25-2E7ABBCDF6A5Q36086631-6EB32857-EAE7-478B-B53F-5341DD246C53Q36738008-95A3A3A9-A533-4E72-9446-1A4489DB7101Q36876345-481A26B4-C3D1-431F-B9A1-5D104F46E948Q37272275-211210AB-D1A1-416D-AC8F-FDDE220A2E70Q37686094-6F85155A-55AA-4AD1-8BC8-F1F84C58A463Q38973028-3A2BA0FC-A299-4D34-BF06-03E9BA27BE45Q39020001-7A60C262-A30F-4179-A967-38818CBEF5F0Q39796585-D30F70F5-1D08-4077-AD40-6946C0FC6214Q40722440-54275E2E-0DB5-490B-976F-1B27D927C8AA
P2860
Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Noncytolytic inhibition of X4 virus by bulk CD8
@nl
Noncytolytic inhibition of X4 ...... t mediated by beta-chemokines.
@en
type
label
Noncytolytic inhibition of X4 virus by bulk CD8
@nl
Noncytolytic inhibition of X4 ...... t mediated by beta-chemokines.
@en
prefLabel
Noncytolytic inhibition of X4 virus by bulk CD8
@nl
Noncytolytic inhibition of X4 ...... t mediated by beta-chemokines.
@en
P2093
P2860
P1433
P1476
Noncytolytic inhibition of X4 ...... t mediated by beta-chemokines.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.17.8306-8316.2001
P407
P577
2001-09-01T00:00:00Z